Parameswaran Nair

18.5k total citations · 9 hit papers
238 papers, 10.0k citations indexed

About

Parameswaran Nair is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Parameswaran Nair has authored 238 papers receiving a total of 10.0k indexed citations (citations by other indexed papers that have themselves been cited), including 180 papers in Physiology, 129 papers in Pulmonary and Respiratory Medicine and 54 papers in Immunology. Recurrent topics in Parameswaran Nair's work include Asthma and respiratory diseases (178 papers), Respiratory and Cough-Related Research (66 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers). Parameswaran Nair is often cited by papers focused on Asthma and respiratory diseases (178 papers), Respiratory and Cough-Related Research (66 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (47 papers). Parameswaran Nair collaborates with scholars based in Canada, United States and United Kingdom. Parameswaran Nair's co-authors include Frederick E. Hargreave, Paul M. O’Byrne, Melanie Kjarsgaard, Sarah Svenningsen, Manali Mukherjee, Ann Efthimiadis, Stephanie Sproule, Peter Barker, Mitchell Goldman and Mario Castro and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Angewandte Chemie International Edition.

In The Last Decade

Parameswaran Nair

228 papers receiving 9.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

2016 984 citations Parameswaran Nair et al. profile →
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia

2009 977 citations Parameswaran Nair, Márcia Margaret Menezes Pizzichini et al. New England Journal of Medicine profile →
Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe Asthma

2017 716 citations Parameswaran Nair, Klaus F. Rabe et al. New England Journal of Medicine profile →
Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study

2011 547 citations Frederick E. Hargreave, Parameswaran Nair et al. profile →
Omalizumab for asthma in adults and children

2014 459 citations Rebecca Normansell, Samantha Walker et al. Cochrane Database of Systematic Reviews profile →
Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia

2015 363 citations Melanie Kjarsgaard, Chynna Huang et al. profile →
Role of Biologics in Asthma

2018 293 citations Parameswaran Nair et al. profile →
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

2022 146 citations Michael E. Wechsler, Parameswaran Nair et al. profile →
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

2024 69 citations Michael E. Wechsler, Parameswaran Nair et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Parameswaran Nair

Since Specialization

Citations

This map shows the geographic impact of Parameswaran Nair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parameswaran Nair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parameswaran Nair more than expected).

Fields of papers citing papers by Parameswaran Nair

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parameswaran Nair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parameswaran Nair. The network helps show where Parameswaran Nair may publish in the future.

Co-authorship network of co-authors of Parameswaran Nair

This figure shows the co-authorship network connecting the top 25 collaborators of Parameswaran Nair. A scholar is included among the top collaborators of Parameswaran Nair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parameswaran Nair. Parameswaran Nair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	XALOC-1 2025 ·CHEST Journal ·(unknown), David J. Jackson, Parameswaran Nair, Benjamin Emmanuel, Trung N. Tran, Andrew Menzies‐Gow, (unknown), Sheena Kayaniyil, (unknown), Javier Nuevo, (unknown), Anat Shavit, Vivian H. Shih, David J. Cohen, Cláudia Chaves Loureiro, Alicia Padilla‐Galo	3
2	Computational fluid dynamics model predictions of inhaled corticosteroid deposition in patients with severe asthma 2025 ·Thorax ·(unknown), (unknown), (unknown), (unknown), (unknown), Melanie Kjarsgaard, (unknown), Anna Dvorkin‐Gheva, Manali Mukherjee, Myrna Dolovich, (unknown), Mark D. Inman, Parameswaran Nair, Sarah Svenningsen	0
3	Achieving remission in severe asthma 2025 ·PubMed ·(unknown), Santi Nolasco, Parameswaran Nair	3
4	S1 Randomised, placebo-controlled trial of astegolimab for COPD with frequent exacerbations: ALIENTO 2025 ·Neil Greening, Christopher E. Brightling, Ruth Tal‐Singer, (unknown), (unknown), (unknown), Parameswaran Nair, Peter Bremner, Nicola A. Hanania, Wim Janssens, Dorothy Cheung, Michele A. Grimbaldeston, Jessica M.Y. Ng, Xinglong Yang, Divya Mohan, C. Franz Vogelmeier	0
5	Contemporary Concise Review 2024: Chronic Obstructive Pulmonary Disease 2025 ·Respirology ·(unknown), Parameswaran Nair	2
6	IL-18 biology in severe asthma 2024 ·Frontiers in Medicine ·(unknown), (unknown), (unknown), Parameswaran Nair, Manali Mukherjee	5
7	Tezepelumab in Adults With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Efficacy and Safety From the Phase 2a COURSE Study 2024 ·(unknown), Mona Bafadhel, Christopher E. Brightling, Klaus F. Rabe, MeiLan K. Han, Mohit Bhutani, Jean Bourbeau, S. Christenson, Mark T. Dransfield, Parameswaran Nair, (unknown), (unknown), Gun Almqvist, (unknown), (unknown), Néstor A. Molfino, Sandhia Ponnarambil	0
8	Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis breakdown → 2024 ·New England Journal of Medicine ·Michael E. Wechsler, Parameswaran Nair, Benjamin Terrier, (unknown), Arnaud Bourdin, David Jayne, David J. Jackson, Florence Roufosse, (unknown), Ying Fan, Maria Jison, Christopher McCrae, Sofia Necander, Anat Shavit, (unknown), Peter A. Merkel	69
9	Sampling pattern discrepancy in the application of compressed sensing hyperpolarized xenon‐129 lung MRI 2024 ·NMR in Biomedicine ·(unknown), Sarah Svenningsen, (unknown), Norman B. Konyer, Parameswaran Nair, Michael D. Noseworthy	1
10	Autoinflammatory gene mutations associated with eosinophilia and asthma 2023 ·Allergy Asthma and Clinical Immunology ·(unknown), (unknown), (unknown), (unknown), Nader Khalidi, Parameswaran Nair	4
11	A Rapid Sputum‐based Lateral Flow Assay for Airway Eosinophilia using an RNA‐cleaving DNAzyme Selected for Eosinophil Peroxidase 2023 ·Angewandte Chemie International Edition ·M. Monsur Ali, Manali Mukherjee, Katherine Radford, (unknown), Alfredo Capretta, Parameswaran Nair, John D. Brennan	12
12	Luminal mucus plugs are spatially associated with airway wall thickening in severe COPD and asthma: A single-centered, retrospective, observational study 2022 ·Respiratory Medicine ·(unknown), (unknown), Ehsan Haider, Colm Boylan, (unknown), (unknown), (unknown), (unknown), Terence Ho, Parameswaran Nair, Sarah Svenningsen, Miranda Kirby	13
13	Effect of anti‐IL‐5 biologics on weight and body mass index 2021 ·Allergy ·Ruth P. Cusack, Chynna Huang, Nicola LaVigne, Imran Satia, Parameswaran Nair, Paul M. O’Byrne	5
14	Review of monoclonal antibody therapies in asthma and allergic diseases - a new paradigm for precision medicine 2020 ·Asian Pacific Journal of Allergy and Immunology ·TH Lee, Parameswaran Nair, Christopher J. Corrigan	4
15	TWIST1 DNA methylation is a cell marker of airway and parenchymal lung fibroblasts that are differentially methylated in asthma 2020 ·Clinical Epigenetics ·Rachel L. Clifford, Chen Xi Yang, Nick Fishbane, (unknown), Julia L. MacIsaac, Lisa M. McEwen, Sean May, (unknown), Parameswaran Nair, Ma’en Obeidat, Michael S. Kobor, Alan J. Knox, Tillie‐Louise Hackett	9
16	Reproducibility of Hyperpolarized 129Xe MRI Ventilation Defect Percent in Severe Asthma to Evaluate Clinical Trial Feasibility 2020 ·Academic Radiology ·Sarah Svenningsen, Marrissa J. McIntosh, Alexei Ouriadov, (unknown), Norman B. Konyer, Rachel L. Eddy, David G. McCormack, Michael D. Noseworthy, Parameswaran Nair, Grace Párraga	24
17	Eosinophil-derived IL-13 promotes emphysema 2019 ·European Respiratory Journal ·Alfred D. Doyle, Manali Mukherjee, William E. LeSuer, (unknown), (unknown), Justin J. Frere, (unknown), Jake A. Kloeber, Kelly P. Shim, Sergei I. Ochkur, Terence Ho, Sarah Svenningsen, Benjamin L. Wright, Matthew A. Rank, James J. Lee, Parameswaran Nair, Elizabeth A. Jacobsen	59
18	Revisiting Type 2‐high and Type 2‐low airway inflammation in asthma: current knowledge and therapeutic implications 2016 ·Clinical & Experimental Allergy ·Douglas S. Robinson, Marc Humbert, Roland Buhl, Álvaro A. Cruz, Hiromasa Inoue, Stephan Korom, Nicola A. Hanania, Parameswaran Nair	269
19	Omalizumab for asthma in adults and children breakdown → 2014 ·Cochrane Database of Systematic Reviews ·Rebecca Normansell, Samantha Walker, Stephen J Milan, E. Haydn Walters, Parameswaran Nair	459
20	Monitoring sputum eosinophils in mucosal inflammation and remodelling: a pilot study 2009 ·European Respiratory Journal ·Jamila Chakir, Lionel Loubaki, Michel Laviolette, Joanne Milot, Sabrina Biardel, Lata Jayaram, Márcia Margaret Menezes Pizzichini, Emílio Pizzichini, Frederick E. Hargreave, Parameswaran Nair, LP Boulet	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact